Physician profile
Rachel Thibodeau
NPI 1912491721
$6,668.53
in general payments reported to CMS, 2019-2025
9 companies · $2,824 in 2025
The $2,824 reported for 2025 was more than what 87% of Surgery of The Hand (Surgery) providers received nationally (typical 2025 total: $285).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $3,845 · 2025: $2,824.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $5,102 · Food and Beverage: $1,528 · Education: $38.12.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $5,102.19 |
| Food and Beverage | $1,528.22 |
| Education | $38.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $2,460.05 | 2024-2025 | |
| Axogen | $1,729.39 | 2024 | Axoguard Ha+ Nerve Protector, Axoguard Nerve Protector, Axoguard Nerve Cap |
| Sonex Health, INC. | $1,005.77 | 2025 | Sx-One Microknife |
| Mf Med | $708.32 | 2025 | |
| Skeletal Dynamics INC | $577.85 | 2024 | Implate, Align, Geminus |
| Medtronic, INC. | $62.48 | 2024 | Signia |
| Endo USA, INC. | $55.18 | 2024-2025 | Xiaflex |
| Orthofix Medical, INC. | $48.25 | 2025 | Physio-Stim |
| Vertex Pharmaceuticals Incorporated | $21.24 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rachel Thibodeau listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.